Hydrogen cyanamide exposure: a case series from Pavia Poison Control Centre.

IF 1.7 4区 医学 Q2 PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH Occupational Medicine-Oxford Pub Date : 2023-12-29 DOI:10.1093/occmed/kqad108
L Bernasconi, M Carnovale, D Lonati, V M Petrolini, A Schicchi, B Brolli, V M Negrini, C Grazioli, O Maystrova, E Buscaglia, Giulia Scaravaggi, F Crema, C A Locatelli
{"title":"Hydrogen cyanamide exposure: a case series from Pavia Poison Control Centre.","authors":"L Bernasconi, M Carnovale, D Lonati, V M Petrolini, A Schicchi, B Brolli, V M Negrini, C Grazioli, O Maystrova, E Buscaglia, Giulia Scaravaggi, F Crema, C A Locatelli","doi":"10.1093/occmed/kqad108","DOIUrl":null,"url":null,"abstract":"<p><strong>Background: </strong>Hydrogen cyanamide is a plant growth regulator introduced in Italy as Dormex in 2000, but recalled from the market in 2008. It's currently not authorized in Europe. Inhalation/dermal contact may cause irritation/caustic burns, ingestion of severe organ damage and concomitant alcohol consumption disulfiram-like reaction due to aldehyde-dehydrogenase inhibition by hydrogen cyanamide.</p><p><strong>Aims: </strong>To study all exposure cases referred to our centre, evaluating temporal and geographic distribution and analysing clinical manifestations, including the ones after alcohol consumption.</p><p><strong>Methods: </strong>We retrospectively evaluated all hydrogen cyanamide exposures referred to our Poison Control Centre (January 2007-December 2021). For each case, age, sex, exposure route/year, geographical location, intent of exposure, alcohol co-ingestion, emergency department-admission Poison Severity Score, signs/symptoms and treatment were analysed.</p><p><strong>Results: </strong>Thirty subjects were included. Median case/year was 1 [1; 2]: 79% occurred after market withdrawal, 92% in Sicily. All exposures were unintentional and work related; 41% of patients also co-ingested alcohol. Mean poison severity score at emergency department admission was 1.54, more severe when ingestion occurred. The most common signs/symptoms were flushing, secondary to peripheral vasodilation (41%), hyperaemia/erythema (29%), dyspnoea (25%), nausea (20%), vomiting (12%), oedema (12%), II-III degrees burns (12%) and pharyngodynia (12%). All patients were treated symptomatically and fully recovered.</p><p><strong>Conclusions: </strong>Hydrogen cyanamide exposure can lead to severe clinical manifestations. Despite its withdrawal from the Italian market, hydrogen cyanamide is still used: through PCC's crucial role in monitoring exposure to agricultural products efforts should be made to contrast illegal trade and increase awareness of its potential toxicity in those countries in which it's still legal.</p>","PeriodicalId":54696,"journal":{"name":"Occupational Medicine-Oxford","volume":" ","pages":"500-506"},"PeriodicalIF":1.7000,"publicationDate":"2023-12-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10756658/pdf/","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Occupational Medicine-Oxford","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/occmed/kqad108","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"PUBLIC, ENVIRONMENTAL & OCCUPATIONAL HEALTH","Score":null,"Total":0}
引用次数: 0

Abstract

Background: Hydrogen cyanamide is a plant growth regulator introduced in Italy as Dormex in 2000, but recalled from the market in 2008. It's currently not authorized in Europe. Inhalation/dermal contact may cause irritation/caustic burns, ingestion of severe organ damage and concomitant alcohol consumption disulfiram-like reaction due to aldehyde-dehydrogenase inhibition by hydrogen cyanamide.

Aims: To study all exposure cases referred to our centre, evaluating temporal and geographic distribution and analysing clinical manifestations, including the ones after alcohol consumption.

Methods: We retrospectively evaluated all hydrogen cyanamide exposures referred to our Poison Control Centre (January 2007-December 2021). For each case, age, sex, exposure route/year, geographical location, intent of exposure, alcohol co-ingestion, emergency department-admission Poison Severity Score, signs/symptoms and treatment were analysed.

Results: Thirty subjects were included. Median case/year was 1 [1; 2]: 79% occurred after market withdrawal, 92% in Sicily. All exposures were unintentional and work related; 41% of patients also co-ingested alcohol. Mean poison severity score at emergency department admission was 1.54, more severe when ingestion occurred. The most common signs/symptoms were flushing, secondary to peripheral vasodilation (41%), hyperaemia/erythema (29%), dyspnoea (25%), nausea (20%), vomiting (12%), oedema (12%), II-III degrees burns (12%) and pharyngodynia (12%). All patients were treated symptomatically and fully recovered.

Conclusions: Hydrogen cyanamide exposure can lead to severe clinical manifestations. Despite its withdrawal from the Italian market, hydrogen cyanamide is still used: through PCC's crucial role in monitoring exposure to agricultural products efforts should be made to contrast illegal trade and increase awareness of its potential toxicity in those countries in which it's still legal.

Abstract Image

Abstract Image

查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
氰胺暴露:帕维亚毒物控制中心的一系列病例。
背景:氰胺氢是一种植物生长调节剂,于2000年在意大利以Dormex的名义引入,但于2008年从市场上召回。它目前未在欧洲获得授权。吸入/皮肤接触可能会引起刺激/腐蚀性烧伤,摄入严重的器官损伤,以及由于氰胺对乙醛脱氢酶的抑制而伴随的饮酒双硫仑样反应。目的:研究转介至我们中心的所有暴露病例,评估时间和地理分布,并分析临床表现,包括饮酒后的表现。方法:我们回顾性评估了我们毒物控制中心(2007年1月至2021年12月)的所有氰胺暴露。对每个病例的年龄、性别、接触途径/年、地理位置、接触意图、共同饮酒、急诊科入院毒物严重程度评分、体征/症状和治疗进行了分析。结果:纳入30名受试者。中位病例/年为1[1;2]:79%发生在市场退出后,西西里岛为92%。所有暴露都是无意的,与工作有关;41%的患者同时摄入酒精。急诊科入院时的平均中毒严重程度评分为1.54,摄入时更严重。最常见的体征/症状是潮红、继发于外周血管舒张(41%)、充血/红斑(29%)、呼吸困难(25%)、恶心(20%)、呕吐(12%)、水肿(12%),Ⅱ-Ⅲ度烧伤(12%)和咽痛(12%)。所有患者均接受了症状治疗并完全康复。结论:氰胺暴露可导致严重的临床表现。尽管氰胺已退出意大利市场,但它仍在使用:通过PCC在监测农产品暴露方面的关键作用,应努力在那些仍然合法的国家对比非法贸易,提高对其潜在毒性的认识。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Occupational Medicine-Oxford
Occupational Medicine-Oxford 医学-公共卫生、环境卫生与职业卫生
CiteScore
5.80
自引率
3.90%
发文量
120
审稿时长
4-8 weeks
期刊介绍: Occupational Medicine is an international peer-reviewed journal which provides vital information for the promotion of workplace health and safety. The key strategic aims of the journal are to improve the practice of occupational health professionals through continuing education and to raise the profile of occupational health with key stakeholders including policy makers and representatives of employers and employees. Topics covered include work-related injury and illness, accident and illness prevention, health promotion, occupational disease, health education, the establishment and implementation of health and safety standards, monitoring of the work environment, and the management of recognized hazards. Contributions are welcomed from practising occupational health professionals and research workers in related fields.
期刊最新文献
The COVID-19 pandemic and occupational health-transitioning to the new normal. Direct-to-consumer occupational health monitoring: opportunities, concerns, ethical considerations. Workplace mental health screening for trauma-exposed workforces. Mental health and employment outcomes in working-age US adults, 2010-2019. Occupational well-being of diplomatic personnel: a qualitative study.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:604180095
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1